Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine
Open accessThe DOI matches its Crossref record; 234 of the 235 references it cites were found in a registry or an index.
Abstract
Earlier research primarily attributed the effects of mesenchymal stem cell (MSC) therapies to their capacity for local engrafting and differentiating into multiple tissue types. However, recent studies have revealed that implanted cells do not survive for long, and that the benefits of MSC therapy could be due to the vast array of bioactive factors they produce, which play an important role in the regulation of key biologic processes. Secretome derivatives, such as conditioned media or exosomes, may present considerable advantages over cells for manufacturing, storage, handling, product shelf life and their potential as a ready-to-go biologic product. Nevertheless, regulatory requirements for manufacturing and quality control will be necessary to establish the safety and efficacy profile of these products. Among MSCs, human uterine cervical stem cells (hUCESCs) may be a good candidate for obtaining secretome-derived products. hUCESCs are obtained by Pap cervical smear, which is a less invasive and painful method than those used for obtaining other MSCs (for example, from bone marrow or adipose tissue). Moreover, due to easy isolation and a high proliferative rate, it is possible to obtain large amounts of hUCESCs or secretome-derived products for research and clinical use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., Deans, R. J., Keating, A., Prockop, D. J., & Horwitz, E. M. (2006) · Cytotherapy · doi:10.1080/14653240600855905 · Cited by 17,766 · cited 1×
“The Mesenchymal and Tissue Stem Cell Committee of the International Society for Cellular Therapy established in 2006 the minimal identifying characteristics for human MSCs [29]: (a) plastic-adherent cells when maintained in standard culture conditions; (b) expression of CD105, CD73 and CD90, and lack expression of CD4…”
BackgroundValadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo
Gronthos, S., Mankani, M., Brahim, J., Robey, P. G., & Shi, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240309797 · Cited by 4,570 · cited 1×
“They have also been isolated from other adult tissues such as adipose tissue [10], skin [11], lung [12], synovial membrane [13], dental pulp [14], nasal olfactory mucosa [15], breast milk [16], scalp tissue [17], muscle [18], periosteum [19], corneal limbus [20], peripheral blood [21], endometrial and menstrual blood…”
BackgroundA perivascular origin for mesenchymal stem cells in multiple human organs
Crisan, M., Yap, S., Casteilla, L., Chen, C.-W., Corselli, M., Park, T. S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.07.003 · Cited by 3,991 · cited 1×
“All of these MCSs can be isolated and expanded from stroma of many tissues, the bone marrow and subcutaneous fat being the preferred sources [28].”
BackgroundDi Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P. D., Matteucci, P., Grisanti, S., & Gianni, A. M. (2002) · Blood · doi:10.1182/blood.v99.10.3838 · Cited by 3,226 · cited 1×
“found that MSCs inhibit proliferation of CD4+ and CD8+ T cells [78].”
BackgroundMesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Le Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M., & Ringdén, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16104-7 · Cited by 2,734 · cited 1×
“The most promising potential applications involve the treatment of graft versus host disease [74,75], as well as of autoimmune and inflammatory diseases, such as insulin systemic lupus erythematosus (SLE), diabetes mellitus type I, (SLE), multiple sclerosis or Crohn’s”
BackgroundFriedenstein, A. J., Chailakhjan, R. K., & Lalykina, K. S. (1970) · Cell Proliferation · doi:10.1111/j.1365-2184.1970.tb00347.x · Cited by 2,724 · cited 1×
“[9], who described a fibroblast-like population able to secrete growth factors and cytokines relevant for hematopoiesis and others processes.”
BackgroundNémeth, K., Leelahavanichkul, A., Yuen, P. S. T., Mayer, B., Parmelee, A., Doi, K., Robey, P. G., Leelahavanichkul, K., Koller, B. H., Brown, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1905 · Cited by 2,364
Stromal fibroblasts in cancer initiation and progression
Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,302 · cited 1×
“This is relevant because CAFs, a prevailing component of tumor stroma, contribute to tumor growth, invasion and dissemination [145,146].”
Background
Research works printed but not linked: 1
- 95. Litwack G. Human Biochemistry and Disease. Academic Press; Cambridge, MA, USA: 2008.
Cited by
Items 401–500 of 1,000
Shibata, S., Hayashi, R., Okubo, T., Kudo, Y., Baba, K., Honma, Y., & Nishida, K. (2019) · Regenerative Therapy · doi:10.1016/j.reth.2019.06.005 · Cited by 27
“Further, paracrine effects are thought to be responsible for the therapeutic effects of MSCs [18], which have been shown to suppress not only internal organ fibrosis such as visceral fibrosis, but also scaring and fibrosis on body surface tissues such as the skin, processes suggested to be mediated by EMT [19e23].”
BackgroundApplication of mesenchymal stem cell-derived exosomes in kidney diseases
Deng, G., Yu, C. J., Zhu, S., Zhu, P., & Nasser, M. I. (2021) · Cellular Immunology · doi:10.1016/j.cellimm.2021.104358 · Cited by 26
Stem Cells in Regenerative Medicine
Casado‐Díaz, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11185460 · Cited by 26
“Among the advantages of the former in regenerative medicine are: (i) can be easily stored; (ii) production of large quantities of cells is not necessary; (iii) can be evaluated for safety, dosage and activity, as conventional pharmaceutical agents; (iv) have a long half-life and stability; (v) can be more easily appli…”
BackgroundExosomes and Biomaterials: In Search of a New Therapeutic Strategy for Multiple Sclerosis
Ojeda-Hernández, D. D., Hernández-Sapiéns, M. A., Reza-Zaldívar, E. E., Canales-Aguirre, A., Matías-Guiu, J. A., Matías-Guiu, J., Mateos-Díaz, J. C., Gómez-Pinedo, U., & Sancho-Bielsa, F. (2022) · Life · doi:10.3390/life12091417 · Cited by 25
“In recent years, several lines of evidence have supported using exosomes (mainly MSCs-derived exosomes to regenerate the nervous system) [63,77,78].”
BackgroundWei, Y., Zhong, S., Yang, H., Wang, X., Lv, B., Bian, Y., Pei, Y., Xu, C., Zhao, Q., Yulan, W., et al. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116496 · Cited by 29
Zhang, Q., Liu, T., Li, Y., Yang, F., Shang, H., Zhao, H., Sun, H., Yu, Z., Han, M., & Wan, C. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.133336 · Cited by 32
Mitochondrial transfer from mesenchymal stem cells: Mechanisms and functions
Liu, Q., Zhang, X., Zhu, T., Xu, Z., Dong, Y., & Chen, B. (2024) · Mitochondrion · doi:10.1016/j.mito.2024.101950 · Cited by 30
Franco, M. L., Beyerstedt, S., & Rangel, É. B. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics14010011 · Cited by 33
Sasaki, G. H. (2022) · Aesthetic Surgery Journal Open Forum · doi:10.1093/asjof/ojac045 · Cited by 28
Urine-derived exosomes from individuals with IPF carry pro-fibrotic cargo
Elliot, S. J., Catanuto, P., Pereira‐Simon, S., Xia, X., Shahzeidi, S., Roberts, E. R., Ludlow, J. W., Hamdan, S., Daunert, S., Parra, J., et al. (2022) · eLife · doi:10.7554/elife.79543 · Cited by 26
Costa, L. A., Eiró, N., Vaca, A., & Vizoso, F. J. (2022) · Bioengineering · doi:10.3390/bioengineering10010004 · Cited by 32
“Furthermore, obtaining enough MSC in 2D or 3D cultures for regenerative treatments is time-consuming, expensive, and usually requires a specialized laboratory [54,72].”
BackgroundSelf-citationQuintero, D., Orfei, C. P., Kaplan, L. D., de Girolamo, L., Best, T. M., & Kouroupis, D. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1040762 · Cited by 28
“in vivo mainly through a paracrine activity was instrumental to proposing a series of studies and applications based on this particular property (Vizoso et al., 2017).”
BackgroundAdvancements in adipose-derived stem cell therapy for skin fibrosis
Liu, Y.-X., Sun, J., Ho, C., Gao, Y., Wen, D., Liu, Y.-D., Huang, L. J., & Zhang, Y. (2023) · World Journal of Stem Cells · doi:10.4252/wjsc.v15.i5.342 · Cited by 25
Tan, S. T., Aisyah, P. B., Firmansyah, Y., Nathasia, N., Budi, E., & Hendrawan, S. (2023) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s408162 · Cited by 27
“This therapeutic principle has been widely used in the field of regenerative medicine, especially chronic wounds.(42) Several previous studies have shown that MSC has the potential to increase wound healing rates by accelerating wound closure time.”
BackgroundInfluentialMendes-Pinheiro, B., Campos, J., Marote, A., Soares‐Cunha, C., Nickels, S., Monzel, A. S., Cibrão, J. R., Loureiro‐Campos, E., Serra, S. C., Barata‐Antunes, S., et al. (2023) · Cells · doi:10.3390/cells12212565 · Cited by 26
“In recent years, compelling evidence has brought attention to the array of bioactive molecules produced by MSCs, collectively known as secretome [6,8,9].”
BackgroundRodríguez, C. I., Porcello, A., Chemali, M., Raffoul, W., Marques, C., Scaletta, C., Lourenço, K., Abdel-Sayed, P., Applegate, L. A., Vatter, F. A. P., et al. (2024) · Cosmetics · doi:10.3390/cosmetics11050154 · Cited by 28
“This fact is attributed to several factors, including the lack of standardization in isolation, purification, and characterization methodologies for exosomes [46,119,120].”
Mesenchymal stem cell-derived secretomes for therapeutic potential of premature infant diseases
Wang, Y., Long, W., Cao, Y., Li, J., You, L., & Fan, Y. (2020) · Bioscience Reports · doi:10.1042/bsr20200241 · Cited by 26
Mesenchymal Stromal Cell Bioreactor for Ex Vivo Reprogramming of Human Immune Cells
Allen, A., Vaninov, N., Li, M., Nguyen, S., Singh, M., Igo, P., Tilles, A. W., O'Rourke, B. P., Miller, B. L. K., Parekkadan, B., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-67039-w · Cited by 31
Hossein‐Khannazer, N., Torabi, S., Hosseinzadeh, R., Shahrokh, S., Aghdaei, H. A., Memarnejadian, A., Kadri, N., & Vosough, M. (2021) · Human Cell · doi:10.1007/s13577-021-00560-w · Cited by 26
Dong, X., Dong, J., & Zhang, J. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01165-6 · Cited by 25
Fine-tuning licensing strategies to boost MSC-based immunomodulatory secretome
Rossello-Gelabert, M., Igartua, M., Santos‐Vizcaíno, E., & Hernández, R. M. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04315-4 · Cited by 30
“…(MSCs) have gained significant attention due to their potent immunomodulatory properties, mediated through interactions with various immune cells – including macrophages, dendritic cells, and T cells – and the secretion of bioactive molecules collectively referred to as the secretome [10, 11].”
A Review on the Etiology and Management of Pediatric Traumatic Spinal Cord Injuries.
Benmelouka, A. Y., Shamseldin, L. S., Nourelden, A. Z., & Negida, A. (2020) · PubMed Central · doi:10.22114/ajem.v0i0.256 · Cited by 25
Innate Immunity Communicates Using the Language of Extracellular Microvesicles
Ratajczak, M. Z., & Ratajczak, J. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10138-6 · Cited by 24
Jiang, M., Liu, J., Liu, W., Zhu, X., Bano, Y., Liao, H., Li, H., & Jiang, H. (2021) · Aging · doi:10.18632/aging.202812 · Cited by 25
“The potential effects of MSCs could be attributed to MSC secretome that contains numerous bioactive factors [13, 15, 25].”
Proteomic Comparison of Bone Marrow Derived Osteoblasts and Mesenchymal Stem Cells
Aasebø, E., Brenner, A. K., Hernandez-Valladares, M., Birkeland, E., Berven, F. S., Selheim, F., & Bruserud, Ø. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115665 · Cited by 24
Hu, Y., Zhang, X., Lin, M., Zhou, H.-Y., Cong, M., Chen, X., Zhang, R., Yu, D., Gao, X., & Guo, T. (2022) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x17666220422093103 · Cited by 29
Application of Nanomaterials in Stem Cell‐Based Therapeutics for Cardiac Repair and Regeneration
Qiu, J., Liu, X., You, B., Ren, N., & Liu, H. (2023) · Small · doi:10.1002/smll.202206487 · Cited by 24
Zhang, C., Liao, W., Li, W., Li, M., Xu, X., Sun, H., Xue, Y., Liu, L., Qiu, J., Zhang, C., et al. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1131701 · Cited by 26
“In addition, compared with MSC treatment, exosome components are relatively simple, and their structural characteristics enable them to reach the target tissues with high efficiency, likely avoiding the risk of long-term abnormal differentiation and tumor formation caused by stem-cell transplantation in the host (Vizo…”
BackgroundComprehensive Bibliometric Analysis of Stem Cell Research in Alzheimer’s Disease from 2004 to 2022
Wang, R., Zhu, Y., Qin, L.-F., Xu, Z., Gao, X.-R., Liu, C., Xu, G., & Chen, Y. (2023) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000528886 · Cited by 25
Grouw, A. V., Colonna, M. B., Maughon, T. S., Shen, X., Larey, A. M., Moore, S. G., Yeago, C., Fernández, F. M., Edison, A. S., Stice, S. L., et al. (2023) · Stem Cells · doi:10.1093/stmcls/sxad039 · Cited by 24
Ebrahimi, F., Pirouzmand, F., Pecho, R. D. C., Alwan, M., Mohamed, M. Y., Ali, M. S., Hormozi, A., Hasanzadeh, S., Daei, N., Hajimortezayi, Z., et al. (2023) · Biotechnology Progress · doi:10.1002/btpr.3374 · Cited by 24
“10 MSCs such as dental pulp mesenchymal stem cells (DP-MSCs) have also shown a satisfactory potential for further research into regenerative medicine.”
BackgroundChen, S.-Y., Yang, R., Wu, X.-C., Zhao, D., Fu, S.-P., Lin, F.-Q., Li, L., Yu, L., Zhang, Q., & Zhang, T. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s428425 · Cited by 26
“122 Mesenchymal stem cells from umbilical cord blood promotes the polarization of M2 macrophages and reduces IL-7 and IFN-γ, TNF-α, at the same time, they increased the expression of IL-4 and IL-13.”
BackgroundEquine Musculoskeletal Pathologies: Clinical Approaches and Therapeutical Perspectives—A Review
Reis, I. L., Lopes, B., Sousa, P., Sousa, A. C., Caseiro, A. R., Mendonça, C., Santos, J. M., Atayde, L. M., Alvites, R., & Maurício, A. C. (2024) · Veterinary Sciences · doi:10.3390/vetsci11050190 · Cited by 34
“However, the secretome of individual cells and tissues is specific, and changes in response to fluctuations in physiological states or pathological conditions [199].”
BackgroundInfluentialВалерьевич, С. М., Kotova, S., Shekhter, A. B., Свистушкин, В. М., Акованцева, А. А., Frolova, A., Fayzullin, A. L., Викторовна, С. С., Bezrukov, E. A., Sukhanov, R. B., et al. (2019) · Journal of Microscopy · doi:10.1111/jmi.12784 · Cited by 24
“According to the review (Vizoso et al., 2017), the secreted wide spectrum of anti-inflammatory mediators and cytokines, as well as different growth factors, has a greater significance in wound healing than direct proliferation of stem cells at the site of their implantation.”
BackgroundMultiomics characterization of mesenchymal stromal cells cultured in monolayer and as aggregates
Doron, G., Klontzas, M. E., Mantalaris, A., Guldberg, R. E., & Temenoff, J. S. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27317 · Cited by 27
Bousnaki, M., Bakopoulou, A., Κritis, A., & Koidis, P. T. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-09980-x · Cited by 26
“Additionally, MSC-CM/Exos/MVs treatments can be assessed for safety, dosage and efficacy similarly to conventional pharmaceutical agents, while storage can be done for a respective amount of time without potency reduction [55].”
BackgroundInfluentialMuhammad, S. A., Nordin, N., Hussin, P., Mehat, M. Z., Kasim, N. H. A., & Fakurazi, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0238449 · Cited by 24
Zhou, P., Liu, H., Liu, X., Ling, X., Xiao, Z., Zhu, P., Zhu, Y., Lu, J., & Zheng, S. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-02114-7 · Cited by 24
Miniature auto‐perfusion bioreactor system with spiral microfluidic cell retention device
Yin, L., Au, W. Y., Yu, C. C., Kwon, T., Lai, Z., Shang, M., Warkiani, M. E., Rosche, R., Lim, C. T., & Han, J. (2021) · Biotechnology and Bioengineering · doi:10.1002/bit.27709 · Cited by 26
“MSCs and their secretome have been widely investigated for therapeutic uses in recent decades (Cosenza et al., 2018; Cunningham et al., 2018; Galipeau & Sensebe, 2018; Reza‐Zaldivar et al., 2018; Teixeira et al., 2017; Vizoso et al., 2017).”
MethodPinto, D. D. S., Ahsan, T., Serra, J., Fernandes‐Platzgummer, A., Cabral, J. M. S., & da Silva, C. L. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29622 · Cited by 25
“Depicting the content of this cell secretome may allow physicians to move towards cell‐free therapies (Vizoso et al., 2017).”
BackgroundMachine Learning in Stem Cells Research: Application for Biosafety and Bioefficacy Assessment
Zaman, W. S. W. K., Karman, S. B., Ramlan, E. I., Tukimin, S. N., & Ahmad, M. Y. (2021) · IEEE Access · doi:10.1109/access.2021.3056553 · Cited by 29
“Generally, cell therapy protocols require hundreds of millions of MSC per treatment and this would require cell expansion in vitro for about 10 weeks before implantation [8].”
BackgroundCrescentic Glomerulonephritis: Pathogenesis and Therapeutic Potential of Human Amniotic Stem Cells
Mushafi, A. A., Ooi, J. D., & Odobasic, D. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.724186 · Cited by 25
“In addition, hAEC secretome may be evaluated for safety, dosage and potency in an approach similar to that used for traditional medications (Vizoso et al., 2017).”
MethodHou, Y., Liu, X., Guo, Y., Liu, D., Guo, P., & Liu, J. (2022) · World Neurosurgery · doi:10.1016/j.wneu.2022.02.012 · Cited by 23
Choi, Y. J., Kim, W. R., Kim, D. H., Kim, J. H., & Yoo, J. H. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03678-4 · Cited by 26
“The CM, which combines these elements, offers advantages over whole MSCs, including reduced risks of tumorigenicity and immunological issues and ease of storage [46–48].”
BackgroundKhan, R. S., Dine, K. E., Wessel, H., Brown, L., & Shindler, K. S. (2019) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000000760 · Cited by 23
“Secretions from stem cells provide some key advantages, including the potential to be purified, stored, and dosed precisely compared with stem cells (25,26).”
Ţuţuianu, R., Rosca, A., Kaya, M. G. A., Prună, V., Neagu, T. P., Lascăr, I., Simionescu, M., & Titorencu, I. D. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15507 · Cited by 25
Yang, J., Liu, F., Wang, J., Cheng, M., Wang, S., & Xu, D. (2020) · World Journal of Stem Cells · doi:10.4252/wjsc.v12.i7.688 · Cited by 26
Chen, L., Mou, S., Hou, J., Fang, H., Zeng, Y., Sun, J., & Wang, Z. (2020) · Regenerative Biomaterials · doi:10.1093/rb/rbaa038 · Cited by 23
“A series of researches have shown that mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) could promote tissue repairing and regeneration, as they retain similar features of their sourced cell [9].”
BackgroundZhang, Z., Zhang, L., Yang, J., Huang, J., Cai, J., Zhang, S., Feng, X., & Wang, Q. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10866 · Cited by 23
“It has been reported that the therapeutic efficacy is attrib‑ uted to the secretion of extracellular nanovesicles, secreted bilipid membrane vesicles of 40‑100 nm in diameter that have the natural ability to transmit intercellular signals, such as carrying small RNAs, DNA and proteins (27).”
Potential of Dental Pulp Stem Cell Exosomes: Unveiling miRNA-Driven Regenerative Mechanisms
Chansaenroj, J., Kornsuthisopon, C., Chansaenroj, A., Samaranayake, L. P., Fan, Y., & Osathanon, T. (2024) · International Dental Journal · doi:10.1016/j.identj.2024.08.019 · Cited by 25
Lefevre, C., Panthu, B., Naville, D., Guibert, S., Pinteur, C., Elena‐Herrmann, B., Vidal, H., Rautureau, G. J. P., & Mey, A. (2019) · Stem Cells International · doi:10.1155/2019/9323864 · Cited by 26
Nuzzo, A. M., Moretti, L., Mele, P., Todros, T., Eva, C. E., & Rolfo, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031674 · Cited by 23
“PDMSCs-CM composition is complex and it includes free proteins, small molecules, and extracellular vesicles which can be further divided into apoptotic bodies, microparticles, and exosomes [46,47].”
BackgroundExosomes: A promising therapeutic strategy for intervertebral disc degeneration
Wang, C., Guo, S., Gu, Q., Wang, X., Long, L., Xiao, C., Xie, M., Shen, H., & Li, S. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.111806 · Cited by 24
Stem Cell’s Secretome Delivery Systems
Umar, A. K. (2022) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2023.027 · Cited by 24
“Secretome can quickly spread to other tissues/organs such as the liver, lung, spleen, kidney, heart, muscle, and possibly brain within 30 minutes of injection.(26,27) As a result, a controlled and localized delivery system is needed to improve the secretome's retention and efficacy in the target tissue.”
BackgroundChen, K., Xiong, J., Xu, S., Wu, M., Xue, C., Wu, M., Lv, C., & Wang, Y. (2022) · Stem Cells International · doi:10.1155/2022/5014895 · Cited by 24
“However, the tumorigenicity of ADSC and the storage and transport of cellular products are still controversial, and there is a lack of uniform standards for the application of ADSC products [9, 10].”
BackgroundMahdavi-Jouibari, F., Parseh, B., Kazeminejad, E., & Khosravi, A. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1021024 · Cited by 23
Hodge, J., Decker, H. E., Robinson, J. L., & Mellott, A. J. (2023) · Wound Repair and Regeneration · doi:10.1111/wrr.13076 · Cited by 23
Zhou, Y., Li, Q., You, S., Jiang, H., Jiang, L., He, F., & Hu, L. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10576-4 · Cited by 22
“Mesenchymal stem cells (MSCs) are a type of adult stem cells and exist in various tissues, such as bone marrow, umbilical cord, menstrual blood, etc. [4].”
BackgroundShao, Y., Jiang, Y., Yang, K., Zhu, Y., Liu, Y., Zhang, P., Lv, L., Zhang, X., & Zhou, Y. (2023) · Cell Proliferation · doi:10.1111/cpr.13547 · Cited by 24
Secretome as a Tool to Treat Neurological Conditions: Are We Ready?
da Silva, A. V., Serrenho, I., Araújo, B. S. G. D. S. P., Carvalho, A. M., & Baltazar, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216544 · Cited by 25
“From a preparation point of view, exosomes are stable and can be stored in much smaller volumes than CM [5].”
BackgroundInfluentialResearch progress and challenges of stem cell therapy for ischemic stroke
Cha, Z., Qiao, Y., Lu, Q., Wang, Q., Lu, X., Zhou, H., & Li, T. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1410732 · Cited by 26
“Stem cells can also balance the immune system, which helps prevent excessive activation of immune cells, reduce in fl ammation by releasing signaling molecules, and improve the long-term prognosis of stroke (Vizoso et al., 2017; Zhou et al., 2019; Liu et al., 2021).”
BackgroundOxysterols and mesenchymal stem cell biology
Levy, D., de Melo, T. C., Ruiz, J. L. M., & Bydlowski, S. P. (2017) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2017.06.009 · Cited by 23
Ochs, J., Barry, F., Schmitt, R. H., & Murphy, M. J. (2017) · Cell and Gene Therapy Insights · doi:10.18609/cgti.2017.073 · Cited by 24
“MSC therapies may be based on the potential of the cells to differentiate to mesenchymal lineages or on their paracrine effects on host tissue [7,9].”
BackgroundSchneider, J., Mateo, E., Marcos‐Arias, C., Eiró, N., Vizoso, F. J., Pérez-Fernández, R., Eraso, E., & Quindós, G. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02818 · Cited by 24
Self-citationKale, V. P. (2019) · Stem Cells and Development · doi:10.1089/scd.2019.0149 · Cited by 22
“Although, initially it was thought that the MSCs bring about regenerative changes via tissue-specific differentiation and integration, it was soon realized that they exert their therapeutic effects via their secretome [8].”
Modulation of the Dental Pulp Stem Cell Secretory Profile by Hypoxia Induction Using Cobalt Chloride
Bhandi, S., Alkahtani, A., Mashyakhy, M., Alsofi, L., Maganur, P. C., Vishwanathaiah, S., Testarelli, L., Giudice, A. D., Mehta, D., Vyas, N., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11040247 · Cited by 23
“The collective term for these extracellular secretions is secretory profile [11,12].”
Cheng, J., Hsu, C., Hsu, S.-L., Chou, W., Wu, Y., Kuo, C. A., Hsu, T.-C., Shiu, L., & Jhan, S.-W. (2021) · Biomedicines · doi:10.3390/biomedicines9101399 · Cited by 24
Chen, Y., Lu, C.-H., Ke, C., & Liu, R.-S. (2021) · Membranes · doi:10.3390/membranes11100796 · Cited by 26
Diabetes complications and extracellular vesicle therapy
Soltani, S., Mansouri, K., Parvaneh, S., Thakor, A. S., Pociot, F., & Yarani, R. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09680-y · Cited by 22
Shuler, K. T., Wilson, B. E., Muñoz, E. R., Mitchell, A. D., Selsby, J. T., & Hudson, M. B. (2020) · Cells · doi:10.3390/cells9122544 · Cited by 23
Nadesh, R., Menon, K. N., Biswas, L., Mony, U., Iyer, K. S., Vijayaraghavan, S., Nambiar, A., & Nair, S. V. (2021) · Scientific Reports · doi:10.1038/s41598-021-01878-z · Cited by 22
Venugopal, C., Shobha, K., Rai, K. S., & Dhanushkodi, A. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.12.012 · Cited by 22
Can a Scaffold Enriched with Mesenchymal Stem Cells Be a Good Treatment for Spinal Cord Injury?
Blando, S., Anchesi, I., Mazzon, E., & Gugliandolo, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147545 · Cited by 21
“The secretome of MSCs contains soluble proteins, free nucleic acids, lipids, and extracellular vesicles [68].”
BackgroundWang, X., Wang, Q., Yin, P., Chen, L., Zhao, X., Wen, D., & Tan, Y. (2022) · Cell and Tissue Research · doi:10.1007/s00441-022-03697-8 · Cited by 21
Yusharyahya, S. N., Japranata, V. V., Sitohang, I. B. S., Legiawati, L., Novianto, E., Suseno, L. S., & Rachmani, K. (2023) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s401839 · Cited by 26
“Furthermore, relatively lower immunogenicity, and the uncomplicated handling, render ADMSCs secretome more favorable over the cell line for therapeutic purposes.(8,9) Apart from the type of ADMSCs-based product, administration techniques are also deemed to affect the outcomes.”
BackgroundTaheri, M., Tehrani, H. A., Dehghani, S., Alibolandi, M., Arefian, E., & Ramezani, M. (2024) · Medicinal Research Reviews · doi:10.1002/med.22023 · Cited by 21
Zhang, X., Gao, X., Zhang, B., Yao, X., & Kang, X. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s469302 · Cited by 27
“14,15 However, the extraction, administration method, dose, source, growth state, and culture conditions of EVs affect their biological functions, 13 and the currently extracted and stored EVs are not yet ready for commercialization, with cumbersome extraction steps, high costs, and storage…”
BackgroundLi, Y., Gao, X., & Wang, J. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5606 · Cited by 22
Kot, M., Musiał-Wysocka, A., Lasota, M., Ulman, A., & Majka, M. (2019) · Acta Biochimica Polonica · doi:10.18388/abp.2019_2895 · Cited by 25
“All of these biological features, combined with ease of culture expansion, make MSCs highly investigated stem cells and the most commonly used cells in regenerative medicine (Lee et al., 2010; Wang et al., 2012; Wei et al., 2013; Hare et al., 2017).”
BackgroundAbdolmohammadi, K., Mahmoudi, T., Nojehdehi, S., Tayebi, L., Hashemi, S. M., Noorbakhsh, F., Abdollahi, A., Soleimani, M., Nikbin, B., & Nicknam, M. H. (2020) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2020.036 · Cited by 23
“17,20,22,27,29,30 Proteomics analysis of MSC-CM has identified more than 100 proteins (including cytokines, chemokines and growth factors) with anti-inflammatory, anti-apoptotic, anti-fibrotic and regenerative effects.”
Cui, H. S., Joo, S. Y., Cho, Y. S., Park, J. H., Kim, J., & Seo, C. H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103675 · Cited by 27
“Likewise, another characteristic of MSCs is their strong paracrine property, releasing various cytokines, growth factors, and chemokines to modulate all phases of the wound-healing process, including accelerated wound closure, increased angiogenesis, decreased wound inflammation, and regulation of extracellular matrix…”
BackgroundOverview of stem cells therapy in amyotrophic lateral sclerosis
Je, G., Keyhanian, K., & Ghasemi, M. (2021) · Neurological Research · doi:10.1080/01616412.2021.1893564 · Cited by 23
“Cell therapy focused on replacement of degenerated motor neurons is challenging due to the pathogenic complexity and anatomical distribution of degeneration sites; however, transplanted MSCs may instead exert beneficial roles through influencing non-cell autonomous disease mechanisms like releasing neurotrophic factor…”
BackgroundJoerger-Messerli, M. S., Thomi, G. F., Haesler, V., Keller, I., Renz, P., Surbek, D., & Schoeberlein, A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.622539 · Cited by 21
Dzobo, K. (2021) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2021.0049 · Cited by 25
“The contrasting data as presented above demonstrate the importance of accurate reporting and understanding the effects of MSCs and factors they release on cancer cells (Lazennec and Jorgensen, 2008; Vizoso et al., 2017).”
Wei, S., Cheng, R., Li, S., Lu, C., Zhang, Q., Wu, Q., Zhao, X., Tian, X., Zeng, X., & Liu, Y. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02922-6 · Cited by 21
“Recent research has particularly explored the paracrine effects of MSCs [23–25], highlighting the roles of extra-cellular vesicles, such as exosomes (exos) and microvesicles (MVs), which can partially or completely mimic the functions of their originating cells [26].”
Mesenchymal Stromal Cells Preconditioning: A New Strategy to Improve Neuroprotective Properties
Schepici, G., Gugliandolo, A., & Mazzon, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042088 · Cited by 27
“In this regard, MSCs can release trophic and growth factors, microRNAs, cytokines and extracellular vesicles (EVs), which, together, constitute the secretome [11,15,16].”
BackgroundSuhandi, C., Mohammed, A. F. A., Wilar, G., El‐Rayyes, A., & Wathoni, N. (2023) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-023-00570-9 · Cited by 26
“The secretome refers to a collection of bioactive molecules that are generated and released by cells into the extracellular matrix [14, 15].”
BackgroundJammes, M., Cassé, F., Velot, É., Bianchi, A., Audigié, F., Contentin, R., & Galéra, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814169 · Cited by 23
“However, the use of purified exosomes has been found to offer greater safety and standardization advantages than the use of the entire MSC secretome [25].”
BackgroundAhmed, L. A., & Al‐Massri, K. F. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-03916-z · Cited by 22
“More research is still required to select the best route of systemic administration of MSC-exos (intravenous, subcutaneous, or intramuscular routes) [128].”
BackgroundEmerging Strategies in Mesenchymal Stem Cell-Based Cardiovascular Therapeutics
Kumar, R., Mishra, N., Tran, T., Kumar, M., Vijayaraghavalu, S., & Gurusamy, N. (2024) · Cells · doi:10.3390/cells13100855 · Cited by 25
“The MSC secretome, which encompasses a range of bioactive factors, including growth factors, cytokines, and chemokines, contributes to immunomodulation, homeostasis, tissue repair, and regeneration [119–121].”
BackgroundDental pulp stem cells: Novel cell-based and cell-free therapy for peripheral nerve repair
Sultan, N., Amin, L. E., Zaher, A. R., Scheven, B. A. A., & Grawish, M. E.-A. (2019) · World Journal of Stomatology · doi:10.5321/wjs.v7.i1.1 · Cited by 24
Dietary phytochemical approaches to stem cell regulation
Zhang, S., Lam, K.-H., Wan, J. H., Yip, C. W., Liu, H. K.-H., Lau, Q. M.-N., Man, A. H.-Y., Cheung, C. H. A., Wong, L. H., Chen, H., et al. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.103822 · Cited by 23
Kim, Y. S., Suh, D., Tak, D. H., Chung, P. K., Kwon, Y. B., Kim, T. Y., & Koh, Y. G. (2020) · Journal of Experimental Orthopaedics · doi:10.1186/s40634-020-00310-1 · Cited by 24
“Despite the capability of MSCs to differentiate into mesodermal cell lineages including cartilage, initial regenerative claims concerning therapeutic effects in OA have been revised due to recent evidence suggesting that paracrine and anti-inflammatory actions are crucial for tissue-restoring effects of MSC treatments…”
BackgroundYao, Y., Xia, Z., Cheng, F., Jang, Q., He, J., Pan, C., Zhang, L., Ye, Y., Wang, Y., Chen, S., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02358-x · Cited by 20
“Recent studies now support that the beneficial effects observed with MSC-based therapy can be mediated through the paracrine release of soluble proteins or other biologically active molecules and extracellular vesicles, which together constitute the MSC secretomes [6, 16, 25, 28, 29].”
BackgroundHu, X., Liu, L., Wang, Y., Yu, Y., Li, Z., Liu, Y., & Chai, J. (2022) · Stem Cells International · doi:10.1155/2022/8661689 · Cited by 21
“Indeed, there were a few of MSCs that survive for more than one week after systemic administration, suggesting that the main e ff ects of MSCs are probably mediated by paracrine mechanisms [24].”
BackgroundMesenchymal stem cells: A new therapeutic tool for chronic kidney disease
Wang, J., Lin, Y., Chen, X., Liu, Y., & Zhou, T. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.910592 · Cited by 22
“Using MSCs-EVs instead of MSCs would have many advantages in clinical applications, like addressing safety issues such as tumorigenicity, embolisms, and infection transmission through injected cells, as well as making it easier to store them (Vizoso et al., 2017).”
BackgroundEffects of FGF 21‐secreting adipose‐derived stem cells in thioacetamide‐induced hepatic fibrosis
Kang, H., Seo, E., Park, J., Han, N., Lee, H., & Jun, H. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13795 · Cited by 20
“The therapeutic effect of MSC therapy is due to a variety of biologically active factors produced by them.(14) Our study showed that CM from FGF21_ADSCs significantly inhibited TGF‐β‐induced expression of fibrogenic factors compared with CM from Empty_ADSCs.”
ResultDeryabin, P. I., Griukova, A., Shatrova, A. N., Petukhov, A., Nikolsky, N. N., & Borodkina, A. V. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1593650 · Cited by 20
“In this context, genetic modification allows to manage MSCs secretome precisely by varying the expression levels of the exact genes (reviewed in [21]).”
BackgroundMirabdollahi, M., Sadeghi‐Aliabadi, H., & Javanmard, S. H. (2020) · PubMed Central · doi:10.22038/ijbms.2020.42477.10020 · Cited by 21
“Compared with chemotherapeutic agents, the use of hWJMSCs-derived secretome as an anticancer treatment has several advantages such as acting in a tumor specific manner, inducing or augmenting antitumor immune responses, and also inducing growth inhibition of different tumors (37).”
BackgroundLerussi, G., Villagrasa-Araya, V., Moltó‐Abad, M., del Toro, M., Pintos‐Morell, G., Seras‐Franzoso, J., & Abasolo, I. (2025) · Life · doi:10.3390/life15010070 · Cited by 22
“These properties are critical in the context of neuroinflammatory diseases, such as multiple sclerosis or traumatic brain injury, and might also be relevant in LSDs [148].”
Metadata
- Authors
- Vizoso, F., Eiro, N., Cid, S., Schneider, J., & Perez-Fernandez, R.
- Affiliations
- Fundación Hospital de Jove (ES)
- Research Unit, Fundación Hospital de Jove, Avda. Eduardo Castro, 161, 33290 Gijón, Spain
- Department of Obstetrics & Gynecology, C/Ramon y Cajal 7, University of Valladolid, 47005 Valladolid, Spain
- Department of Physiology-Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, 15706 Santiago de Compostela, Spain
- Corresponding author
- Vizoso, Francisco
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-08-25
- Volume
- 18
- Issue
- 9
- Pages
- 1852
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5618501
- OpenAlex
- W2746710261
- Cited by
- 1,363
- References
- 235
- Citations by year
- 2026: 142 · 2025: 165 · 2024: 153 · 2023: 182 · 2022: 186 · 2021: 178 · 2020: 158 · 2019: 130 · 2018: 62 · 2017: 6
- FWCI
- 13.75
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Science Council
- European Regional Development Fund (SAF2015-69221-R)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Dentistry › Periodontics › Periodontal Regeneration and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- mesenchymal stem cells, secretome, cell-free therapy, conditioned medium, exosomes, regenerative medicine, stem cell therapy, quality control, regulatory requirements
- MeSH terms
- Clinical Studies as Topic, Animals, Humans, Stem Cells, Culture Media, Conditioned, Regenerative Medicine, Mesenchymal Stem Cell Transplantation, Cell-Derived Microparticles, Exosomes, Mesenchymal Stem Cells, Cell- and Tissue-Based Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.